Detalhe da pesquisa
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature;
610(7931): 343-348, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36071165
2.
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.
BMC Cancer;
22(1): 526, 2022 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35545761
3.
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Nat Med;
29(8): 2110-2120, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37488289
4.
The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.
Cancer Res;
80(15): 3062-3069, 2020 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32245795